It has been documented that B7-H4 has a tumor-promoting role in addition to T-cell inhibition [17], and it was shown that overexpression of B7-H4 in Caki-1 cells led to less sensitivity to the chemotherapeutic agents doxorubicin or docetaxel [20]. Here, VTCN1 is linked to neoplasm.